Artwork

Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 117 - Brensocatib for Bronchiectasis and Alteplase for Posterior Circulation Ischemic Stroke

26:08
 
Share
 

Manage episode 481357031 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast. This week, Dr. Mike Fralick and special guest Dr. Laiya Carayannopoulos from the Intern at Work Podcast and our Medicine Pods collaboration discuss two recent papers: the use of brensocatib (a DPP-1 inhibitor) to treat bronchiectasis, and the effect of alteplase administered 4.5 to 24 hours after stroke in patients with mild posterior circulation stroke who did not receive thrombectomy. Two papers, here we go!

  1. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (0:00 – 12:46)
  2. Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (12:47 – 24:55)

And for the Good Stuff (24:56 – 26:08):

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

374 episodes

Artwork
iconShare
 
Manage episode 481357031 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast. This week, Dr. Mike Fralick and special guest Dr. Laiya Carayannopoulos from the Intern at Work Podcast and our Medicine Pods collaboration discuss two recent papers: the use of brensocatib (a DPP-1 inhibitor) to treat bronchiectasis, and the effect of alteplase administered 4.5 to 24 hours after stroke in patients with mild posterior circulation stroke who did not receive thrombectomy. Two papers, here we go!

  1. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (0:00 – 12:46)
  2. Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (12:47 – 24:55)

And for the Good Stuff (24:56 – 26:08):

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

  continue reading

374 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play